HAL (France)open access
Neoplastic risk in hyperplastic esophagogastric junction lesions: Comprehensive multicenter study
1, Hepatocellular Child B Liver function Immunotherapy Immune checkpoint inhibitors, 2, Precancerous conditions &amp, Cancerous lesions displasia and cancer stomach, Albi score Anti-PD-1 Carcinoma, 0, EMRc
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 176782
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.